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An integrase dimer can process and integrate a single HIV-1 DNA end in vitro, whereas a tetramer is required to integrate two ends. LEDGF/
p75 can potently stimulate integrase activity, but its effects on half- versus full-site integration have not been investigated. Stimulation of half-site
but inhibition of full-site integration is revealed here. LEDGF/p75 seems to interfere with integrase oligomerization, but does not inhibit the
catalytic activity of pre-assembled complexes. We therefore speculate that LEDGF/p75 function is restricted to a point in the viral lifecycle that
occurs after the formation of the preintegration synaptic complex, for example, as a chromatin-associated tethering factor.
© 2006 Elsevier Inc. All rights reserved.Keywords: Integrase; Full-site integration; HIV-1; LEDGF/p75Introduction
Integrase (IN) catalyzes two sequential reactions, 3′ proces-
sing and DNA strand transfer, first removing a 3′-GT
dinucleotide from the U5 and U3 ends of reverse transcribed
HIV-1 cDNA. The recessed ends are then used by IN to affect a
double-stranded staggered cut in chromosomal DNA, which at
the same time joins the viral ends to protruding 5′-phosphates.
In vitro, IN can process the 3′ end of a donor (D) oli-
gonucleotide substrate that models the U3 or U5 viral end and
then integrate that end into a second oligonucleotide that serves
as a surrogate chromosomal DNA (Bushman and Craigie,
1991). Including a heterologous circular target DNA in the
reaction helps determine the extent that strand transfer yields the
coupled integration of two D ends, referred to here as full-site
(FS) integration. Initial experiments revealed that HIV-1 IN
prefers to integrate one viral end into one strand of target DNA
to generate half-site (HS) reaction products as compared to
integrating two ends with a 5 bp spacing, as occurs in vivo
(Bushman and Craigie, 1991; Goodarzi et al., 1995). Sub-
sequent work revealed that maintaining relatively low protein⁎ Corresponding author. Fax: +1 617 632 3113.
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2005) or increasing D DNA length and ensuring that the
reaction proceeds via the 3′ processing step by assaying blunt-
ended as compared to pre-cleaved substrates (Li and Craigie,
2005) significantly increased FS integration but did not
eliminate HS product formation. Chemically crosslinked IN
dimers and tetramers were furthermore shown to specifically
mediate HS and FS integration, respectively, indicating that the
multimeric state of IN protein in large part dictates the outcome
of the different pathways (Faure et al., 2005). The lentiviral IN-
interacting protein lens epithelium-derived growth factor
(LEDGF)/p75 binds to tetrameric recombinant IN in human
cells, stimulates the in vitro activities of purified IN protein
(Cherepanov et al., 2003), and plays a crucial role during HIV-1
integration in vivo (Llano et al., 2006a; Vandekerckhove et al.,
2006). To gain insight into the role of LEDGF/p75 during
integration, we characterized its influences on HS versus FS
HIV-1 product formation in vitro.
Results and discussion
A 972 bp restriction fragment harboring 191 bp of the
downstream end of HIV-1 cDNA served as DDNA. Two aspects
of this substrate were previously shown to favor FS integration
Fig. 1. In vitro integration assay. (A) Schematic diagram of substrate and
reaction products. U5 sequences (short bold lines) are at one end of D DNA (thin
parallel lines). D–D integration can yield linear D2 or branched D2* products.
Integration of one D end into pGEM-3 (solid bold line) yields HS tagged circles,
whereas MT circles arise from additional integrations into HS products. FS
integration proceeds via a pair of D ends attacking both strand of target DNA in a
concerted fashion. (B) Influence of LEDGF/p75 on IN product formation. Lane
1, labeled 1 kb markers; lane 2, mock reaction lacking proteins; lane 3,
integration assay in the absence of BSA and LEDGF/p75; lane 4, assay
conducted in the presence of BSA and IN; lane 5, IN and LEDGF/p75. LEDGF/
p75 suppressed FS product formation in multiple (n=7) independent integration
assays.
2 Rapid Communication(Li and Craigie, 2005): (i) a blunt end, requiring IN to process the
GT dinucleotide prior to DNA strand transfer, and (ii) its relative
length. Supercoiled pGEM-3 (2876 bp) was included in the
reaction; integration of one D end into one strand of pGEM-3
yields a tagged circle HS product (Fig. 1A). A separate D
molecule can instead serve as target, resulting in the integration
of one D end into another. Depending on the relative location
of D/D insertion, the resultant dimer will be a Y-shaped
branch (D2*, internal integration site) or migrate as a linear
1.9 kb DNA through agarose (D2, integration close to the
DNA end). HS or D2 product formation proceeds via a dimer
of IN engaging a processed D end and either pGEM-3 or
another D molecule, respectively, in what is referred to here
as a non-synaptic complex (NSC) (Faure et al., 2005; Guiot et
al., 2006). Repeated HS integration into the same pGEM-3
molecule yields multiple-tagged (MT) circles (Fig. 1A).
Similarly, HS reactions utilizing D2 products as target result
in formation of donor multimers, Dn. FS integration of two D
ends into both strands of pGEM-3 yields a linear 4.8 kb
product, reminiscent of viral integration in vivo (Fig. 1A).
This pathway proceeds via a synaptic complex (SC), whereby
a dimer of IN dimers assembled at two D ends engages one
pGEM-3 molecule for integration (Li et al., 2006).
Preliminary experiments optimized reaction conditions for
maximal levels of IN activity and LEDGF/p75 stimulation. In
the absence of added accessory proteins, ∼63% of input D was
converted to integration products (Fig. 1B, lane 3). The
formation of significant levels of apparent end-to-end linear
D2 integrants is consistent with results of previous studies that
likewise utilized relatively long D substrates (Cherepanov et al.,
1999; Li and Craigie, 2005). The level of IN activity and pattern
of integration products were unaffected by including the control
bovine serum albumin (BSA) protein in the reaction (Fig. 1B,
compare lane 4 to lane 3). When LEDGF/p75 was substituted
for BSA (lane 5), there was an∼8% increase in the overall level
of IN activity (9.6±3.6% for n=5 replicates) as well as a
significant shift in the pattern of strand transfer reaction
products.
LEDGF/p75 preferentially inhibited the formation of a
product that migrated to a position consistent with FS
integration (4.8 kb; Fig. 1B, lane 5). To probe the linearity of
this species (Fig. 1A) and gain insight into other reaction
products, excised gel lanes were electrophoresed in a second
orthogonal dimension. The second dimension distinguishes
linear DNAs such as input D and FS products, which migrate
along an arc, from non-linear, branched DNAs (Dn, HS and MT
integration products) because these migrate above the arc
(Friedman and Brewer, 1995). In the absence of LEDGF/p75
(Fig. 2A), three species, D substrate (lower right corner) and D2
and FS products, traveled along the arc defined by the migration
positions of co-electrophoresed linear marker fragments. The
HS, MT, and branched Dn products in comparison migrated
above the arc, as predicted. Comparable levels of HS (51%) and
FS (49%) products formed, and the total fraction of NSC-
mediated products (HS, MT, and D2–6) was ∼78%. This is not
unexpected as NSCs form via tri-molecular events whereas SCs
require the interaction of five molecular players for theirformation. Analysis of LEDGF/p75-containing reactions con-
firmed that the host factor stimulated the formation of NSC-
mediated products and inhibited the formation of a linear 4.8 kb
species (Fig. 2B). Previous studies would indicate that the vast
majority of linear 4.8 kb products harbor a 5 bp duplication of
target sequence resulting from the coupled integration of two
viral DNA ends (Li and Craigie, 2005), though we note that an
analogous cloning and sequence analysis was not conducted
here.
To investigate protein determinants affecting FS product
formation, LEDGF/p75 mutants defective for IN (LEDGFD366N)
or DNA binding (LEDGF226–530) were analyzed. FS integration
Fig. 2. 2D gel and mutant analyses. (A) IN-alone reaction from lane 3 in Fig. 1B. (B) LEDGF/p75-containing reaction (Fig. 1B, lane 5). Relative orientations of
electrophoretic dimensions are shown. The arc indicates the migration path of unlabeled 1 kb linear markers; the FS product migrated between the 4 and 5 kb
fragments. *, non-linear D2 and D3 products. Similar results were obtained in three side-by-side comparisons of 2D electrophoretic patterns. (C) LEDGF/p75 mutant
analysis. The portion of the gel harboring FS and HS products is shown.
3Rapid Communicationwas unimpaired by the IN-binding mutant, whereas the 226–530
deletion mutant, which retains IN-binding and stimulates IN
activity in vitro (Turlure et al., 2006), suppressed FS integration
similar to wild-type LEDGF/p75 (Fig. 3C, lanes 3–6). Suppres-
sion of FS integration therefore requires IN binding and appears to
occur independent of LEDGF/p75 DNA binding activity.
Our results indicate that LEDGF/p75 either interferes with
SC formation or affects its disassembly during the course of theFig. 3. SC assembly and reaction time course. (A) Different schemes to account
for SC formation and FS integration. The curved arrow preceding step iv
illustrates a theoretical reorientation within the nucleoprotein complex (Wang et
al., 2001). See text for additional details. (B) Integration time course. Reactions
in lanes 1–11 were treated with proteinase K or LEDGF/p75 at the indicated
times. The portion of the gel harboring HS and FS products is presented for
simplicity; D2 and MT products were formed at levels proportional to HS levels.
Results are representative of those obtained in two independent time course
experiments.reaction. The IN dimer can process and integrate individual D
ends (Faure et al., 2005; Guiot et al., 2006) and higher order
multimers, including the tetramer, can dissociate into monomers
and dimers upon DNA binding (Deprez et al., 2001). Different
scenarios may therefore be envisioned for SC formation. IN
dimers can bind D DNA, interact with one another to form the
active tetramer, and then engage target DNA (Fig. 3A, assembly
pathway ii) (Li et al., 2006). Alternatively, the dimeric complex
might engage target DNA (Fig. 3A, assembly pathway i) prior
to tetramer formation (Fig. 3Aiii). Both D DNA ends within the
SC moreover need not concomitantly integrate into target (Li et
al., 2006), providing evidence for a theoretical “reorientation”
step based on the crystal structure of tetrameric HIV-1 IN1–212
(Wang et al., 2001). The two active sites most likely to catalyze
DNA strand transfer within the tetramer model were further
apart (∼40 Å) than expected for FS integration into normal B-
form DNA (∼15 Å). It was therefore proposed that sequential
end integration and reorientation of protein subunits within the
tetramer might regulate DNA strand transfer such that the
second end becomes integrated 5 bp away from the first (Wang
et al., 2001). Thus, we envisioned that LEDGF/p75 might
interfere with FS product formation by competing for IN
dimer–dimer interactions (Fig. 3A, branch ii and/or iii) or
interfere with a potential reorientation step within assembled
SCs that harbor a single integrated end (branch iv).
To probe if LEDGF/p75 predominantly interferes with SC
assembly/function or affects its disassembly, an order-of-
addition experiment was performed wherein the host factor
was added at different times throughout a 1 h experimental
4 Rapid Communicationplatform. In parallel, proteinase K was added instead of
LEDGF/p75. Thus, as a function of time, proteinase K revealed
the extent and types of products formed by IN up until that point
independent of LEDGF/p75. Comparing these results to those
generated in the LEDGF/p75-containing reactions yielded the
effects of the host factor on the nucleoprotein complexes that
had been formed by IN until that time. In the absence of
LEDGF/p75, the ratio of HS:FS products in this experiment was
∼3:1 (Fig. 3B, lane 11). As expected, adding proteinase K at the
reaction onset negated product formation (Fig. 3B, lane 1).
Approximately 30% of IN-alone HS integration had occurred
by 10 min (compare lane 3 to lane 11), and this product
accumulated over time such that ∼58% of it was apparent by
20 min (lane 5), ∼77% by 30 min (lane 7), and ∼90% by
40 min (lane 9). In stark contrast, appreciable levels of FS
integration were not observed until 30 min after the start of the
reaction, at which time the product had accumulated to ∼35%
of its final level (lanes 3, 5, 7, and 11). The time lag required to
detect appreciable levels of FS (lane 7) versus HS (lane 3)
products indicates that NSC assembly occurs significantly faster
and therefore may potentially serve as an intermediate to SC
formation under these conditions.
As established above, adding LEDGF/p75 at the start of the
reaction (Fig. 3B, lane 2) interfered with FS integration while
enhancing the formation of HS products (∼27% stimulation of
HS integration as compared to IN alone in lane 11). Adding
LEDGF/p75 10 min after the start of the reaction (lane 4)
likewise prevented FS product formation. Significantly, intro-
ducing LEDGF/p75 at 20 min did not prevent FS integration
(lane 6). Since significant levels of FS products had failed to
form by this time in reactions lacking LEDGF/p75 (lane 5), we
infer that the SCs that had formed by 20 min into the reaction
but had yet to catalyze integration (lane 5) were not inhibited
from completing this task by the presence of LEDGF/p75
during the final 40 min of the time course. The result argues
against LEDGF/p75-dependent disassembly of SCs or inter-
ference with a potential reorientation step required for FS
integration. A substantial boost in the level of HS product
formation upon adding LEDGF/p75 at 40 min (compare lane 10
to lane 9) substantiates the conclusion that NSC formation
occurs significantly faster than SC formation.
Adopting an assay system (Li and Craigie, 2005) that utilizes
relatively long, blunt-ended D DNA to effect FS integration, we
determine that LEDGF/p75 stimulates HS product formation
yet preferentially inhibits FS HIV-1 integration in vitro. This
result was somewhat unanticipated as LEDGF/p75 binds
tetrameric IN in human cells (Cherepanov et al., 2003) and is
important for virus integration (Llano et al., 2006a; Vandekerc-
khove et al., 2006). A variety of reports moreover indicate that
the tetramer is likely to catalyze FS HIV-1 integration (Faure et
al., 2005; Guiot et al., 2006; Li et al., 2006). The results of
order-of-addition experiments allow us to conclude that
LEDGF/p75 does not disassemble SCs that are assembled by
IN-alone acting on D DNA. Furthermore, any potential
reorientation of DNA-bound IN subunits that might be required
to bring a second end into a spatial register to complete FS
integration (Wang et al., 2001) is not inhibited by LEDGF/p75.Although NSCs form significantly faster than SCs under our
reaction conditions, we highlight that our results do not address
whether the NSC serves as an intermediate to SC formation.
Numerous studies indicate that LEDGF/p75 functions as a
molecular tether in the cell. A conserved PWWP domain and
dual copy of the AT-hook DNA-binding motif in the N-terminal
half of LEDGF/p75 impart chromatin-binding function (Llano et
al., 2006b; Turlure et al., 2006) whereas the IN-binding domain
in the C-terminal half of the protein can tether IN (Llano et al.,
2006b; Maertens et al., 2003; Vanegas et al., 2005), the cellular
factor JPO2 (Maertens et al., 2006), or perhaps the HIV-1
preintegration complex (PIC) to chromatin for integration
(Llano et al., 2006a). On the other hand, LEDGF/p75 has been
identified as a component of HIV-1 PICs in cytoplasmic extracts
of acutely infected cells (Llano et al., 2004) and can efficiently
restore PIC function following an in vitro salt-depletion step
(Vandegraaff et al., 2006). Therefore, an important issue to
address is whether PIC or chromatin-associated LEDGF/p75
might supply the critical host function in vivo.
Based on the results of this study, we speculate that LEDGF/
p75 is likely to perform its task as a chromatin-associated factor.
In this scenario, SC formation in the PIC is mediated by IN
independent of LEDGF/p75 and, upon engaging LEDGF/p75,
the IN within the SC would be encouraged to integrate at or
nearby the site of LEDGF/p75 binding (Ciuffi et al., 2005).
Consistent with this model, both the chromatin and IN-binding
functions of LEDGF/p75 were critical for virus integration
(Llano et al., 2006a). Our results however do not exclude the
possibility that LEDGF/p75 might play its important role as a
PIC component. In this case, we would propose that the host
factor is recruited to the PIC after IN dimer–dimer formation or,
if it is present before this event, that HIV-1 has evolved a
mechanism to avoid the LEDGF/p75-IN interaction until the IN
tetramer is effectively in place. Additional experiments that
employ recently described LEDGF/p75-depleted cell culture
systems (Llano et al., 2006a) should allow more detailed
investigations into identifying whether LEDGF/p75 in associa-
tion with chromatin or the PIC plays the predominant role to
affect HIV-1 integration in vivo.
Methods
The 972 bp ScaI–DraIII restriction fragment from pU3U5
(Cherepanov et al., 1999) served as D DNA. Recombinant
proteins were purified as described (Turlure et al., 2006).
Integration reactions (25 μL) containing 20 mM HEPES (pH
7.5), 5 mM dithiothreitol, 10 mM MgCl2, 20 μM ZnCl2, and
100 mM NaCl were assembled by sequential addition of
18 nM D DNA, 11 nM pGEM-3, 0.9–1.8 μM IN, and 0.45–
0.7 μM LEDGF/p75 or BSA where indicated, followed by
addition of Me2SO to 5% (v/v). After 2 to 4 min at room
temperature, polyethylene glycol with an average molecular
weight of 8000 Da was added to 10% (v/v). Reactions
incubated at 37 °C for 60 min were stopped by addition of
EDTA, Na dodecyl sulfate, and proteinase K to the final
concentrations of 10 mM, 0.2%, and 1 mg/mL, respectively,
followed by 30 min at 37 °C. DNAs recovered following
5Rapid Communicationprecipitation with ethanol were fractionated through 0.6%
agarose containing TBE buffer (89 mM Tris base, 89 mM
borate, and 2 mM EDTA) at 5 V/cm for 8 h. Dried gels
scanned on a STORM 820 Molecular Dynamics phosphor-
Imager were quantified using ImageQuant version 1.2. For
the Fig. 3B time course, a scaled-up reaction containing all
components except LEDGF/p75 was assembled. Aliquots
(10 μL) withdrawn at the indicated times were either treated
with proteinase K or LEDGF/p75 (0.7 μM). All reactions
were maintained at 37 °C for an overall time of 60 min.
Two-dimensional (2D) agarose gel electrophoresis was
performed as described (Friedman and Brewer, 1995) with
slight modifications. Samples were electrophoresed in the first
dimension through 0.4% agarose–TBE at 1 V/cm for 19 h at
room temperature. After staining with 0.3 μg/mL ethidium
bromide for 1 h, excised lanes were electrophoresed at 5 V/cm
for 6 h at 4 °C into a 1.1% agarose–TBE gel. The gel was dried,
exposed to a phosphorImager screen, and DNA spots were
quantified as described above.
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